Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s share price gapped up prior to trading on Thursday . The stock had previously closed at $17.39, but opened at $18.04. Sysmex shares last traded at $17.27, with a volume of 3,428 shares traded.
Sysmex Trading Down 0.8%
The stock has a 50-day moving average of $17.30 and a two-hundred day moving average of $18.13. The company has a market cap of $10.86 billion, a P/E ratio of 30.80 and a beta of 1.14. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.30 and a current ratio of 2.97.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its earnings results on Wednesday, May 14th. The company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.16 by ($0.04). The company had revenue of $958.89 million during the quarter, compared to analysts' expectations of $991.22 million. Sysmex had a return on equity of 11.81% and a net margin of 10.56%. On average, equities research analysts predict that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.
Sysmex Company Profile
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
See Also
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
